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Abstract. 
 
SEC35
 
 was identified in a novel screen for 
temperature-sensitive mutants in the secretory pathway 
of the yeast 
 
Saccharomyces cerevisiae
 
 (Wuestehube et al., 
1996. 
 
Genetics
 
. 142:393–406). At the restrictive temper-
ature, the 
 
sec35-1
 
 strain exhibits a transport block be-
tween the ER and the Golgi apparatus and accumulates 
numerous vesicles. 
 
SEC35
 
 encodes a novel cytosolic 
protein of 32 kD, peripherally associated with mem-
branes. The temperature-sensitive phenotype of 
 
sec35-1
 
 
is efficiently suppressed by 
 
YPT1
 
, which encodes the 
rab-like GTPase required early in the secretory path-
way, or by 
 
SLY1-20
 
,
 
 
 
which encodes
 
 
 
a dominant form of 
the ER to Golgi target-SNARE–associated protein 
Sly1p.
 
 
 
Weaker suppression is evident upon overexpres-
sion of genes encoding the vesicle-SNAREs 
 
SEC22
 
, 
 
BET1
 
, or 
 
YKT6
 
. The cold-sensitive lethality that re-
sults from deleting 
 
SEC35
 
 is suppressed by 
 
YPT1
 
 or 
 
SLY1-20
 
. These genetic relationships suggest that 
Sec35p acts upstream of, or in conjunction with, Ypt1p 
and Sly1p
 
 
 
as was previously found for Uso1p. Using a 
cell-free assay that measures distinct steps in vesicle 
transport from the ER to the Golgi, we find Sec35p is 
required for a vesicle docking stage catalyzed by 
Uso1p. These genetic and biochemical results suggest 
Sec35p acts with Uso1p to dock ER-derived vesicles to 
the Golgi complex.
 
P
 
rotein
 
 transport through the secretory pathway oc-
curs via transport vesicles under the direction of a
large set of protein components (Rothman, 1994).
The process can be divided into three stages: (
 
a
 
) vesicle
budding, (
 
b
 
) vesicle docking, and (
 
c
 
) membrane fusion,
with distinct sets of proteins mediating each phase. The
budding step involves recruitment of coat proteins to the
membrane and culminates with the release of coated vesi-
cles (Schekman and Orci, 1996). The docking reaction is
likely to require a set of integral membrane proteins on the
vesicle and target membranes, termed v-SNAREs
 
1
 
 and
t-SNAREs (vesicle- and target membrane-soluble 
 
N
 
-ethyl-
maleimide–sensitive fusion protein [NSF] attachment pro-
tein [SNAP] receptors, respectively), that are thought to
confer specificity through their pair-wise interactions (Söll-
ner et al., 1993
 
b
 
). Small GTP-binding proteins of the rab
family also assist in the docking process (Ferro-Novick
and Novick, 1993), but their precise function is not known.
The fusion step ensues after docking and results in the de-
livery of the vesicular cargo to the next compartment in
the secretory pathway.
Vesicular transport from the ER to the Golgi apparatus
in the yeast 
 
Saccharomyces cerevisiae
 
 has been extensively
characterized. Transport vesicle budding involves the as-
sembly of the COPII coat, composed of the Sec13p/Sec31p
(Pryer et al., 1993; Salama et al., 1993; Barlowe et al.,
1994) and Sec23p/Sec24p heterodimers (Hicke and Schek-
man, 1989; Hicke et al., 1992), under the direction of an in-
tegral membrane protein, Sec12p (Nakano et al., 1988; Bar-
lowe and Schekman, 1993), a small GTPase, Sar1p (Nakano
and Muramatsu, 1989), and a multidomain protein, Sec16p
(Espenshade et al., 1995; Shaywitz et al., 1997). Docking is
thought to require a tethering event mediated by Uso1p
(Cao et al., 1998), the yeast homologue of mammalian
p115 (Barroso et al., 1995; Sapperstein et al., 1995), fol-
lowed by or concurrent with the interaction of a set of ER to
Golgi v-SNAREs, Bet1p, Bos1p, Sec22p (Newman and
Ferro-Novick, 1987; Newman et al., 1990; Ossig et al.,
1991; Shim et al., 1991; Søgaard et al., 1994) and perhaps
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a
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N
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Ykt6p (Søgaard et al., 1994; McNew et al., 1997), with the
cognate t-SNARE on the Golgi, Sed5p (Hardwick and
Pelham, 1992). For some time it was thought that fusion may
be initiated by disassembly of the v/t-SNARE complex
(Söllner et al., 1993
 
a
 
) by yeast SNAP, Sec17p, (Griff et al.,
1992) and NSF, Sec18p (Eakle et al., 1988; Wilson et al.,
1989). However, this concept has been challenged by studies
with a yeast system that reconstitutes homotypic vacuolar
fusion, which suggests the action of Sec18p is before vesicle
docking (Mayer et al., 1996; Mayer and Wickner, 1997). In
addition, a prefusion role for NSF has been supported by
the recent finding that liposomes bearing SNAREs alone
can fuse in the absence of NSF (Weber et al., 1998).
Several proteins involved in the regulation of yeast ER
to Golgi v/t-SNARE complex assembly have been identi-
fied, including Ypt1p, Uso1p, and Sly1p. Ypt1p is a mem-
ber of the rab family of small GTP-binding proteins that
have been identified as important components of almost
every stage in the secretory pathway (Ferro-Novick and
Novick, 1993). Hydrolysis of GTP by rab-like proteins has
been hypothesized to provide the regulatory switch that
controls the fidelity of vesicular transport (Bourne, 1988).
A second protein, Uso1p (Nakajima et al., 1991), appears
to function in the same pathway as Ypt1p (Sapperstein et al.,
1996), and both proteins have been demonstrated to be es-
sential for SNARE complex assembly (Søgaard et al.,
1994; Sapperstein et al., 1996; Lupashin and Waters, 1997).
The third protein, Sly1p, is associated with the t-SNARE
Sed5p (Søgaard et al., 1994). 
 
SLY1
 
 is an essential gene in
yeast (Dascher et al., 1991; Ossig et al., 1991), and Sly1p is
required for ER to Golgi transport in vitro (Lupashin et al.,
1996) and in vivo (Ossig et al., 1991). However, several
lines of evidence, particularly from Sly1p homologues in
other organisms, indicate that Sly1p may also function as a
negative regulator of v/t-SNARE complex assembly, per-
haps by preventing the association of the v- and t-SNAREs
(Hosono et al., 1992; Pevsner et al., 1994; Schulze et al.,
1994). A dominant allele of 
 
SLY1
 
, termed 
 
SLY1-20
 
, is ca-
pable of suppressing mutations in 
 
YPT1
 
 and 
 
USO1
 
, in-
cluding complete deletions (Dascher et al., 1991; Sapper-
stein et al., 1996). Thus, in the presence of Sly1-20p, two
components required for SNARE complex assembly are
no longer essential. We have proposed a model (Sapper-
stein et al., 1996; Lupashin and Waters, 1997) in which
Ypt1p and Uso1p function to relieve the inhibitory action
of Sly1p on SNARE complex assembly. In this model
Sly1-20p can be thought of as a noninhibitory form of
 
SLY1 
 
that renders Ypt1p and Uso1p superfluous.
We believe that the ability of 
 
SLY1-20
 
 to suppress de-
fects in upstream docking regulators can be used to iden-
tify additional components involved in the regulation of
vesicular docking. We have undertaken a genetic screen
(to be presented elsewhere) to isolate novel components
in this pathway which, when mutated, depend upon Sly1-
20p for viability. In the course of this work, we discovered
that two recently identified mutants, 
 
sec34
 
 and 
 
sec35
 
, can
be suppressed by 
 
SLY1-20
 
 and thus satisfy the criterion of
our screen. These mutants were isolated in a novel screen
to identify components involved in transport at any step
between the ER and the 
 
trans
 
-Golgi network (i.e.,
 
 
 
the
Kex2p compartment) in yeast (Wuestehube et al., 1996).
Both 
 
sec34
 
 and 
 
sec35
 
 accumulate the core-glycosylated
form of secretory proteins at the nonpermissive tempera-
ture, indicating a block in ER to Golgi transport. Further-
more, electron microscopy indicated that both 
 
sec34
 
 and
 
sec35
 
 accumulate numerous vesicles upon shift to the re-
strictive temperature (Wuestehube et al., 1996), a hall-
mark of genes whose protein products are involved in the
docking or fusion phase of transport (Kaiser and Schek-
man, 1990). In this report we describe the cloning of 
 
SEC35
 
and analysis of its genetic interactions with other secretory
genes. Strong genetic interaction between 
 
SEC35
 
 and
 
SLY1
 
, 
 
YPT1
 
, and 
 
USO1
 
 suggests that Sec35p may func-
tion in vesicle docking. To test this possibility, we devised
an in vitro transport assay that depends on the addition of
purified Sec35p and Uso1p. Vesicles synthesized in the ab-
sence of functional Sec35p do not fuse with the Golgi com-
partment and remain as freely diffusible intermediates.
Upon addition of Sec35p and Uso1p, vesicles dock to the
Golgi and proceed to membrane fusion. Requirements for
Sec35p at the vesicle docking step correlates our genetic
experiments with the biochemically distinguishable steps of
vesicle docking and membrane fusion.
 
Materials and Methods
 
Strains and Microbial Techniques
 
The 
 
S. cerevisiae
 
 strains used in this work are described in Table I. The
 
sec35-1 
 
strain RSY962 (Wuestehube et al., 1996) was crossed to RSY255
to obtain a 
 
sec35-1
 
 haploid strain with additional auxotrophies. A temper-
ature-sensitive 
 
ura3 leu2
 
 segregant, GWY93, was used for subsequent
analyses. The 
 
SEC35
 
 deletion strain, GWY128, was constructed using the
 
g
 
-transformation method of one-step gene replacement (for review see
Rose, 1995) in which the complete open reading frame (ORF) is replaced
by sequences contained in the yeast integrating vector, pRS305 (Sikorski
and Hieter, 1989). The 
 
sec35
 
D
 
 plasmid, pSV31 (see below), was linearized
with SmaI and used to transform the diploid strain, GWY30. Leu
 
1
 
 trans-
formants were purified and the deletion was confirmed by PCR using
primers in 
 
LEU2 
 
and flanking the deletion. A 
 
sec32-1
 
 strain containing
the 
 
ura3-52
 
 mutation, GWY138, was isolated as a temperature-sensitive
segregant from a cross between RSY954 (
 
sec32-1
 
) and RSY271 (
 
sec18-1
 
),
which could be restored to temperature resistance by the introduction of
pAN109 (2 
 
m
 
m 
 
BOS1
 
). The 
 
sec32-1
 
 mutation is allelic to 
 
BOS1
 
, as deter-
mined by complementation analysis (Wuestehube et al., 1996). The 
 
sec34-2
 
strain (RSY960) was crossed to RSY255 to generate a temperature-sensi-
tive 
 
sec34-2
 
 strain with additional auxotrophies (GWY95). To create dip-
loid strains heterozygous for 
 
sec35-1
 
 and 
 
ypt1-3
 
, GWY93 was mated to
RSY976. The strain heterozygous for 
 
sec35-1
 
 and 
 
uso1-1
 
 was generated
through mating RSY962 to GWY67. The 
 
Escherichia coli
 
 strain used in
this work was XL1-Blue (Stratagene, Inc., La Jolla, CA).
Bacterial strains were grown on standard media (Miller, 1972) and
transformation was performed as described (Hanahan, 1983). Transfor-
mation of yeast was performed by the method of Elble (1992) with the ex-
ception of the library transformation, which was performed by the method
of Schiestl and Geitz (1989). Plasmids were isolated from yeast as de-
scribed (Sapperstein et al., 1996). Yeast strains were maintained on rich
media (YPD) containing 1% Bacto-yeast extract, 2% Bacto-peptone, and
2% glucose, or on synthetic media containing 0.67% yeast nitrogen base
without amino acids, 2% glucose, and the appropriate supplements (Rose
et al., 1990). Synthetic complete media (SC) contains all supplements nec-
essary to support yeast growth. Diploid strains were sporulated at room
temperature in liquid media containing 1% potassium acetate and 0.02%
glucose. Unless otherwise noted, all low-temperature incubations of yeast
strains were at room temperature, which was 
 
z
 
21
 
8
 
C.
 
Plasmids
 
The plasmids used in this work are shown in Table II; plasmid construc-
tion was as follows: 
 
SEC35
 
 (ORF YGR120c) was subcloned from a ge-
nomic library plasmid as an NsiI/BamHI fragment and ligated into the 
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LEU2
 
 centromere (CEN) vector, pRS415, that had been previously di-
gested with PstI and BamHI, creating pSV15. ORF YGR122w was iso-
lated from a genomic library plasmid by digestion with PstI and XhoI and
then insertion into PstI- and XhoI-digested pRS415 to create pSV23.
 
SEC35
 
 was excised from pSV15 as a KpnI/SacI fragment and ligated into
three similarly digested vectors: (
 
a
 
) a 
 
URA3
 
 CEN vector, pRS416, to gen-
erate pSV16; (
 
b
 
) a 
 
URA3
 
 integrating vector, pRS306, to create pSV18;
and (
 
c
 
) a 
 
URA3
 
 2-
 
m
 
m vector, pRS424, to generate pSV17. To construct
the plasmid encoding the glutathione-S-transferase (GST)–Sec35 fusion
protein, pSV29, the 
 
SEC35
 
 ORF was amplified from pSV16 by PCR, plac-
ing a BamHI site adjacent to the sequence encoding the first amino acid of
 
SEC35
 
 and an EcoRI site 3
 
9
 
 to the stop codon (5
 
9
 
 primer: 5
 
9
 
 cgc-gga-tcc-atg-
gtc-aac-agt-cat-ag 3
 
9
 
; 3
 
9 
 
primer: 5
 
9
 
 ccg-gaa-ttc-gtt-ttc-tcc-caa-cta-tg 3
 
9
 
). The
PCR product was digested with BamHI and EcoRI and then ligated into
pGEX-2T (Pharmacia Biotech, Inc., Piscataway, NJ) that had also been
digested with BamHI and EcoRI. The plasmid encoding the His
 
6
 
-Sec35p
fusion protein, pSV20, was generated by first subcloning the above PCR
product into pRS416. 
 
SEC35
 
 was then removed from this plasmid as a
BamHI/HindIII fragment and then ligated into pQE-30 (QIAGEN, Inc.,
Santa Clarita, CA) that had been similarly digested. To generate the plas-
mid used for sequencing the 
 
sec35-1
 
 allele, pSV42, the above primers were
used to amplify the ORF using genomic DNA isolated from the 
 
sec35-1
 
 strain
as a template. The PCR product was digested with BamHI and EcoRI and
ligated into a similarly digested pRS416. The plasmid used to create the
 
SEC35
 
 deletion, pSV31, was constructed in two steps. First, a 921-bp re-
gion immediately 3
 
9
 
 to 
 
SEC35
 
 was amplified by PCR, including an XbaI
site adjacent to the stop codon of 
 
SEC35
 
 (5
 
9
 
 primer: 5
 
9 
 
gct-cta-gag-ttg-gga-
gaa-aac-ttt-c 3
 
9
 
; 3
 
9
 
 primer: 5
 
9
 
 cgc-tgt-agt-att-ctg-agg 3
 
9
 
). This product was
cleaved with XbaI and BamHI (at a site 826 bp from the 3
 
9
 
 end of 
 
SEC35
 
),
and ligated into a similarly digested 
 
LEU2
 
 integrating vector, pRS305.
Second, a 1,300-bp fragment that encodes sequence 5
 
9
 
 to 
 
SEC35
 
 was iso-
lated from pSV16 using a HindIII site just upstream of the first amino acid
in 
 
SEC35
 
 and a second HindIII site in the polylinker of pSV16. This frag-
ment, when ligated into the HindIII site of the plasmid generated in the
first step, resulted in a construct in which sequences flanking 
 
SEC35
 
 are
present in the polylinker of pRS305 with the region 3
 
9 of the ORF in front
of the region 59 of the ORF. To create pSV11, SLY1-20 was excised from
pYCp50-SLY1-20 as a SpeI/ClaI fragment (generated from a partial di-
gest with SpeI because there is a SpeI site internal to the gene) and ligated
into a similarly digested vector, pRS416. To isolate BOS1 from the ge-
nomic fragment that contains several additional genes, the gene was liber-
ated from pAN109 as a NruI/KpnI fragment and ligated into pRS416,
which had been digested with SmaI and KpnI, generating pSK101.
Table I. Strains Used in This Work
Strain Genotype Source
RSY255 MATa ura3-52 leu2-3,2112 R. Schekman (University
of California,
Berkeley, CA)
RSY962 MATa sec35-1 lys2-801 R. Schekman
RSY960 MATa sec34-2 lys2-801 R. Schekman
RSY271 MATa sec18-1 ura3-52 his4-612 R. Schekman
RSY976 MATa ypt1-3 ura3-52 R. Schekman
RSY942 MATa sec22-3 ura3-52 lys2-801 R. Schekman
RSY944 MATa bet1-1 ura3-52 lys2-801 R. Schekman
RSY954 MATa sec32-1 lys2-801 leu2-3,
2112
R. Schekman
RSY1074 MATa sly1ts ura3-1 leu2-3,
2112 trp1 ade2-1
R. Schekman
RSY277 MATa sec21-1 ura3 R. Schekman
NY405 MATa sec4-8 ura3-52 P. Novick
(Yale University
School of Medicine,
New Haven, CT)
NY420 MATa sec19-1 ura3-52 P. Novick
SFNY314 MATa bet3-1 ura3-52 leu2-3,
2112
S. Ferro-Novick
(Yale University)
CKY100 MATa sec27-1 ura3 leu2 C. Kaiser (Massachusetts
Institute of Technology,
Cambridge, MA)
EGY101 MATa ret1-1 ura3 leu2 his3 trp1
suc2-D9
S. Emr (University of
California,
San Diego, CA)
SFT1-1 MATa URA3::sft1-1 sft1D::LEU2 
ura3-52 leu2-3,2112 his3-D200 
trp1-D901 lys2-801 suc2-D9
H. Pelham (Medical
Research Council,
Cambridge, UK)
GWY30 MATa/a ura3-52/ura3-52
leu2D1/leu2D1
trp1 D63/trp1 D63
This laboratory
GWY67 MATa uso1-1 ura3-52 leu2-3,
2112
This laboratory
GWY93 MATa sec35-1 ura3-52 leu2-3,
2112
This study
GWY128 MATa/a sec35D::LEU2/SEC35
ura3-52/ura3-52 leu2D1/leu2D1
trp1D63/trp1D63
This study
GWY138 MATa sec32-1 ura3-52 his4-612
lys2-801
This study
GWY95 MATa sec34-2 ura3-52 leu2-3,
2112 lys2-801
This study
Table II. Plasmids Used in This Work
Plasmid Description Source
pJG103 2 mm SEC22 URA3 S. Ferro-Novick
pSFN2d 2 mm BET1 URA3 S. Ferro-Novick
pAN109 2 mm BOS1 URA3 S. Ferro-Novick
pNB167 2 mm YPT1 URA3 S. Ferro-Novick
pGR3 2 mm BET3 URA3 S. Ferro-Novick
pSED5 2 mm SED5 URA3 H. Pelham
pSFT1 2 mm SFT1 URA3 H. Pelham
pNB657 2 mm SEC19 URA3 P. Novick
pNB142 2 mm SEC4 URA3 P. Novick
pYEpSNC1 2 mm SNC1 LEU2 J. Gerst (Weismann
Institute of Science,
Rehovot, Israel)
pYEpSNC2 2 mm SNC2 LEU2 J. Gerst
pSLY1-LEU2 2 mm SLY1 LEU2 H.D. Schmitt (Max
Planck Institute,
Gottingen, Germany
pSK60 2 mm YKT6 URA3 This laboratory
pSK47 2 mm USO1 URA3 This laboratory
pPI2 2 mm VTI1 URA3 This laboratory
pSK101 2 mm BOS1 URA3 This study
pSV17 2 mm SEC35 URA3 This study
pNB166 CEN YPT1 URA3 S. Ferro-Novick
pYCp50-SLY1-20 CEN SLY1-20 URA3 H.D. Schmitt
pSV11 CEN SLY1-20 URA3 This study
pSV15 CEN SEC35 LEU2 This study
pSV16 CEN SEC35 URA3 This study
pSV23 CEN YGR122w LEU2 This study
pSV42 CEN sec35-1 URA3 This study
pSV18 YIp SEC35 URA3 This study
pSV31 YIp sec35D LEU2 This study
pSV29 GST-Sec35p This study
pSV20 His6-Sec35p This study
pRS424 YEp URA3 P. Hieter (Johns Hopkins
School of Medicine,
Baltimore, MD)
pRS415 YCp LEU2 P. Hieter
pRS416 YCp URA3 P. Hieter
pRS305 YIp LEU2 P. Hieter
pRS306 YIp URA3 P. Hieter
pGEX-2T GST-fusion vector Pharmacia Biotech, Inc.,
Piscataway, NJ
pQE-30 His6-fusion vector QIAGEN, Inc., Santa
Clarita, CAThe Journal of Cell Biology, Volume 141, 1998 1110
Cloning of SEC35
To clone SEC35, GWY93 was transformed with two YCp50-based URA3
libraries containing inserts of 10–15 kb and 15–20 kb (A1 and B1, respec-
tively) (Rose et al., 1987). Temperature-resistant transformants were se-
lected directly by incubation at 37.58C for 2 d on SC-URA media. After
confirming the temperature resistance of each colony by retesting on YPD
media at 37.58C, plasmids were isolated from each temperature-resistant
transformant and used to retransform the sec35-1 strain. Plasmids that
conferred temperature resistance were subjected to restriction digest anal-
ysis to eliminate duplicate isolates and to identify overlapping fragments.
Five plasmids from each library were end-sequenced by the dideoxy chain
termination method (Sanger et al., 1977) using primers that flank the in-
sert site in YCp50 (YEp24-F and YEp24-R; Sapperstein et al., 1996), and
the resulting sequences were used to search the Saccharomyces Genome
Database with the BLAST algorithm (Altschul et al., 1990). A 9-kb region
was common to all the library clones and contained two uncharacterized
ORFs, YGR120c and YGR122w, and the gene encoding an ammonium
transporter, MEP1 (Marini et al., 1994). Both novel ORFs were subcloned
individually into pRS415, generating pSV16 and pSV23 (refer to plasmid
construction).
For integrative mapping, pSV18 was digested at a unique site within
SEC35 (SnaBI) and used to transform GWY93. The resulting tempera-
ture-resistant strain was mated to a wild-type strain of the opposite mating
type, and the diploid was sporulated and subjected to tetrad analysis.
Sequencing of the sec35-1 Allele
The UV-generated sec35-1 allele was sequenced by the Princeton Univer-
sity sequencing facility (Princeton, NJ) from plasmid pSV42 (see above).
The ORF was sequenced using primers homologous to the polylinker of
pRS416 (T3: 59 aat-taa-ccc-tca-cta-aag-gg 39; and KS: 59 tcg-agg-tcg-acg-
ggt-atc 39).
Suppression Analysis
To test for suppression of the sec35-1 strain, GWY93 was transformed
with the following plasmids (see Table II): pSV16, pSV11, pSK60, pSK47,
pJG103, pSFN2d, pSK101, pNB166, pNB167, pGR3, pSED5, pSFT1,
pNB657, pNB142, pPI2, pSLY1-LEU2, pYEpSNC1, and pYEpSNC2. Pu-
rified transformants were grown to stationary phase at 218C in synthetic
media. Suppression was tested by spotting the saturated culture and five
10-fold dilutions onto YPD plates followed by incubation for 4 d at 37.58C.
Suppression of the secretory mutants shown in Table I by pSV17 (2 mm of
SEC35 URA3) was tested by streaking purified transformants for single
colonies on YPD plates followed by incubation at 37.58C. Suppression of
the bet3-1 strain was assessed at 308C.
To test the suppression of the SEC35 deletion strain, the sec35D/SEC35
heterozygous deletion strain (GWY128) was transformed with pSV16,
pSV11, and pNB167. Purified transformants were sporulated and dis-
sected on YPD plates. Suppression of the deletion was assessed after 5
(pSV16) or 7 (pSV11 and pNB167) d of growth at 218C.
Metabolic Labeling and Immunoprecipitation of 
Carboxypeptidase Y 
Strains were grown at room temperature in SC media lacking methionine
(SC-MEI) or SC-URA-MET media to an OD595 of 0.3–0.6. For each
strain, one OD unit of cells was pelleted, resuspended in 0.5 ml of the
same media in which it was grown, and then preshifted to 398C for 45 min.
This incubation and all those subsequent were conducted at 398C in a
shaking water bath. Cells were radiolabeled for 10 min with 50 mCi
Tran35S-label (ICN Radiochemicals, Irvine, CA), followed by a 20-min
chase, initiated by the addition of a one twenty-fifth volume of chase mix
(250 mM cysteine, 250 mM methionine). The reactions were stopped by
addition of an equal volume of 20 mM sodium azide and a one-fiftieth vol-
ume of 10 mg/ml cycloheximide, and then placed on ice for 10 min. Cell lysis
and immunoprecipitation of carboxypeptidase Y (CPY) was performed as
previously described (Sapperstein et al., 1996). Antibodies against CPY
were provided by S. Emr (University of California, San Diego, CA).
Purification of Recombinant Proteins from E. coli
To purify GST–Sec35p, the fusion protein was expressed in XL1-Blue
from pSV29. After growth of a 500-ml bacterial culture at 378C to an
OD595 of 1.0, expression of the fusion protein was induced by the addition
of isopropylthiogalactoside to 0.5 mM. After a 4-h induction period, cells
were harvested (7,000 g for 10 min at 48C in a rotor [model SA600; Sorvall
Inc., Newtown, CT]), resuspended in 25 ml PBS, and then lysed by sonica-
tion. To prevent nonspecific protein–protein interaction, Triton X-100
(Sigma Chemical Co., St. Louis, MO) was added to 1%, and the lysate was
rocked at 48C for 30 min. After removal of debris and insoluble protein by
centrifugation (12,000 g for 10 min at 48C in a rotor [model SA600; Sorvall
Inc.]), the lysate was incubated with 2 ml of glutathione–Sepharose beads
(Pharmacia Biotech, Inc., Piscataway, NJ) with gentle end-over-end mix-
ing for 2 h at 48C. The beads were washed twice with 25 ml PBS/1% Triton
X-100 and loaded into a 2-ml column. The fusion protein was eluted with
5 ml of 20 mM reduced glutathione in 50 mM Tris-Cl, pH 8.0.
To purify His6-Sec35p, a 500-ml culture of XL1-Blue transformed with
pSV20 was grown, induced, and then processed as described above. The
clarified bacterial sonicate containing 1% Triton X-100 was incubated
with 2 ml Ni21-NTA-agarose (QIAGEN, Inc., Santa Clarita, CA) for 2 h
at 48C with end-over-end mixing. The beads were washed twice with 25 ml
PBS/1% Triton X-100 and then twice with 25 ml wash buffer (50 mM so-
dium phosphate, pH 6.0, 300 mM NaCl, 10% glycerol; QIAGEN, Inc.,
Santa Clarita, CA). The beads were transferred to a 2-ml column and
His6-Sec35p was eluted with 250 mM imidazole in wash buffer. For use in
the in vitro assay (see below), His6-Sec35p was further purified by size-
exclusion chromatography to ensure that it was monomeric: 200 ml of a
sample containing 5 mg of protein was chromatographed through a 24-ml
Superose 12 column (model HR10/30; Pharmacia Biotech, Inc.) at 0.3 ml/
min in 25 mM Hepes/KOH, pH 7.0, 150 mM KOAc, 1 mM DTT.
Antibody Production and Purification
To generate antigen for antibody production, Sec35p was excised from the
purified GST–Sec35p fusion protein by cleavage with thrombin (Boeh-
ringer Mannheim, Indianapolis, IN) during dialysis against 50 mM Tris-Cl,
pH 8.0, for 12 h at 48C. The GST moiety and any uncleaved fusion protein
was removed by passage of the material over a 2-ml glutathione–
Sepharose column and collecting the Sec35p-containing column flow-
through. Recombinant Sec35p was used for the preparation of polyclonal
antibodies in rabbits by standard protocols (Harlow and Lane, 1988) at
the Princeton University (Princeton, NJ) animal facility. A Sec35p affinity
column, generated by coupling 20 mg of His6-Sec35p (purified as de-
scribed above) to 3.5 ml cyanogen bromide-activated Sepharose according
to the manufacturer’s specifications (Pharmacia Biotech, Inc.), was used
to affinity purify antibodies to Sec35p (Harlow and Lane, 1988).
Preparation of Protein Extracts and Immunoblotting
Total yeast protein extracts were prepared as described (Ohashi et al.,
1982). Samples were separated by SDS-12% PAGE, transferred to nitro-
cellulose, and then probed with the appropriate primary antibodies ac-
cording to standard protocols (Harlow and Lane, 1988). Affinity-purified
antibodies against Sec35p were made as described above, antibodies
against Sed5p were generated and affinity purified as described previously
(Lupashin and Waters, 1997), and monoclonal antibodies against phos-
phoglycerate kinase (PGK) were from Molecular Probes, Inc. (Eugene,
OR). Horseradish peroxidase–conjugated secondary antibodies (Bio-Rad
Laboratories, Hercules, CA) were used at a dilution of 1:3,000. Incuba-
tions with both primary and secondary antibodies were for 1 h at room
temperature. Immunoblots were developed with the chemiluminescent
detection kit (Amersham Corp., Arlington Heights, IL).
Subcellular Fractionation and Extractions
A 250-ml culture of RSY255 was grown in YPD media to an OD595 of 0.5–
1.0, washed in distilled water, and then resuspended at 30 OD/ml in ice-
cold buffer 88 (20 mM Hepes/KOH, pH 7.0, 150 mM KOAc, 5 mM
Mg[OAc]2) containing 1 mM DTT, 1 mM PMSF, 5 mM 1,10-phenanthro-
line, 2 mM pepstatin A, 2 mg/ml aprotinin, and 0.5 mg/ml leupeptin. One-
half the sample volume of acid-washed glass beads (0.45-mm diameter;
Thomas Scientific, Swedesboro, NJ) was added to the mixture, which was
then vortexed six times for 20 s with 1-min incubations on ice between
each burst. To remove unlysed cells, the crude yeast lysate was centri-
fuged at 1,000 g for 3 min at 48C in a rotor (model SA600; Sorvall, Inc.).
The supernatant was diluted to 5 mg/ml in buffer 88 and used for several
manipulations. First, to examine the total membrane-associated pool of
Sec35p, the S1 supernatant was layered over a 14% sucrose cushion (in
buffer 88), centrifuged at 175,000 g for 60 min at 48C in a rotor (modelVanRheenen et al. Sec35p Is Required for Vesicle Docking 1111
TLA100.2; Beckman Instruments, Palo Alto, CA), and separated into the
S175 and P175 fractions. Second, the S1 supernatant was centrifuged at
10,000 g for 15 min at 48C in a rotor (model SA600; Sorvall, Inc.) to gener-
ate the supernatant (S10) and pellet (P10) fractions. The S10 was layered
over a 14% sucrose cushion (in buffer 88) and then centrifuged at 175,000 g
to generate the supernatant (S175) and pellet (P175) fractions. Finally, to
perform protein extractions, 0.5 ml of the S1 supernatant was mixed with
an equal volume of either buffer 88 or one of the three extraction solu-
tions (2% Triton X-100 in buffer 88, 2M NaCl in buffer 88, and 200 mM
Na2CO3 in H2O) and then incubated on ice for 30 min. The extracts were
then layered over a 14% sucrose cushion adjusted to the final concentra-
tion of the extraction solution (1% Triton X-100 in buffer 88, 1 M NaCl in
buffer 88 or 100 mM Na2CO3 in H2O, respectively), centrifuged at 175,000 g
for 60 min, and then separated into the S175 and P175 fractions. For all
175,000 g centrifugation steps, 0.8 ml of sample was layered over a 0.2 ml
sucrose cushion and, after centrifugation, the supernatant fractions were
removed in a total of 0.9 ml, thus distributing the cushion between the su-
pernatant and pellet fractions.
In Vitro ER to Golgi Transport Assay
Yeast semi-intact cells from either wild-type (RSY255) or the sec35-1
strain (RSY962) were prepared from log phase cultures of strains grown
at 238C and stored frozen at 2708C (Baker et al., 1988). Before assays, a
tube of cells was quickly thawed and washed three times in buffer 88 to re-
move cytosol, with each wash followed by centrifugation at 12,000 rpm in
a refrigerated centrifuge (model 5417; Eppendorf Scientific, Inc., Ham-
burg, Germany). [35S]-pre-pro-a-factor was posttranslationally translo-
cated into ER membranes of semi-intact cells at 108C as previously de-
scribed (Baker et al., 1988). After washing semi-intact cells with buffer 88,
vesicle docking and transport assays were performed at the indicated tem-
peratures (Barlowe, 1997; Cao et al., 1998). Briefly, the addition of purified
COPII proteins buds ER-derived vesicles from semi-intact cells that are
freely diffusible and remain in the supernatant fraction after centrifugation
at 14,000 rpm. Protease-protected glycosylated [35S]pro-a-factor ([35S]gp-
a-factor) contained in these vesicles was quantified after solubilization
and precipitation with concanavalin A–Sepharose. For transport assays,
COPII proteins in addition to purified Uso1p, LMA1 and His6-Sec35p
were added as indicated in the figure legends, and then the amount of
Golgi-modified [35S]gp-a-factor was measured by immunoprecipitation
with anti-a1,6-mannose–specific antibodies. The data presented is the av-
erage of duplicate determinations and the error bars represent the range.
Results
Cloning of SEC35
SEC35 was cloned by complementation of the tempera-
ture-sensitive phenotype of the sec35-1 strain. The sec35-1
strain was transformed with a CEN-based library, and tem-
perature-resistant transformants were selected directly by
incubation at the restrictive temperature. Greater than 50
genome equivalents were screened and 32 temperature-
resistant colonies were obtained. To test plasmid linkage
of the temperature-resistant phenotype, plasmids were iso-
lated from each of the temperature-resistant colonies and
used to retransform the sec35-1 strain. The ends of the ge-
nomic inserts of 10 plasmids that restored temperature re-
sistance were sequenced, and the resulting nucleotide se-
quences were used to search the Saccharomyces Genome
Database (http://genome-www.stanford.edu/Saccharomy-
ces/). Each of the plasmids contained a fragment of chro-
mosome VII, and a 9-kb region bearing two uncharacter-
ized ORFs and a gene encoding an ammonium transporter,
MEP1 (Marini et al., 1994), was common to all of them.
Each of the two novel ORFs was subcloned into a CEN-
plasmid and tested for its ability to complement the tem-
perature-sensitive phenotype of the sec35-1 strain. Only
one of the two ORFs, designated YGR120c in the Saccha-
romyces Genome Database, restored growth at 37.58C to
wild-type levels.
To determine whether YGR120c encoded authentic
Sec35p or a low copy number suppressor, integrative map-
ping was performed. A plasmid bearing YGR120c and
URA3 was cleaved at a unique site within the coding se-
quence of YGR120c to direct integration into its genomic
locus in the sec35-1 strain. The resulting Ura1 tempera-
ture-resistant strain was mated to a wild-type strain and
the diploid was sporulated and dissected. Of the 24 tetrads
examined, all segregants were temperature resistant. Since
the temperature-sensitive phenotype did not segregate
away from the integrated plasmid that was marked by
URA3, the cloned gene is very tightly linked to the tem-
perature-sensitive sec35-1 mutation. Therefore, integra-
tive mapping confirms that YGR120c is SEC35.
Sequence of Sec35p and Sec35-1p
The predicted protein sequence encoded by SEC35 is
shown in Fig. 1 a. Sec35p is composed of 275 residues and
has a calculated mass of 31.8 kD and a pI of 4.56. Sec35p
lacks any hydrophobic stretch of sufficient length to act as
a transmembrane domain, nor does it contain consensus
sequences for lipid modification; thus, it is predicted to be
a cytosolic or peripheral membrane protein. Sec35p shows
no significant propensity to form coiled coils as predicted
by the PairCoil algorithm (Berger et al., 1995), although
the COILS program (Lupas et al., 1991) does identify two
regions of z20 amino acids with greater than 70% proba-
bility of forming coiled coils. Database searches reveal no
homologues of Sec35p.
Figure 1. Predicted amino acid sequence of Sec35p and Sec35-1p.
(a) Protein sequence of Sec35p. SEC35 was sequenced as part of
the Yeast Genome Sequencing project and corresponds to ORF
YGR120c, GenBank/EMBL/DDBJ accession number Z72905.
(b) Sequence of wild-type SEC35 from bp 613 to 628 with the
transversion mutation at bp 624 (t to a) and corresponding codon
change (tyrosine to ochre) present in the sec35-1 allele indicated
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Sequencing of the sec35-1 allele revealed a single base
pair change at base pair 624 (t to a) resulting in the conver-
sion of a tyrosine codon to an ochre stop codon (Fig. 1 b).
The sec35-1 allele thus encodes a truncated protein with a
predicted mol wt of 24 kD. Because the strain containing
this truncation displays no growth defect at temperatures
from 218 to 308C, the carboxy-terminal 68 amino acids of
the protein are not crucial to the function of the protein in
this temperature range.
Deletion of SEC35 Results in a Severe Growth Defect
To determine whether SEC35 is an essential gene, the en-
tire ORF was replaced in a diploid strain by the sequences
in a LEU2 integrating plasmid (refer to Materials and
Methods). After sporulation of the heterozygous deletion
strain, tetrads were dissected on YPD plates and incu-
bated at 308C. Upon incubation for 7 d, tetrads were ob-
served to contain two distinct sizes of colonies, with each
tetrad containing two large and two (or, less frequently,
one) very small segregants (Fig. 2 a). The small segregants
were all Leu1, indicating the presence of the disruption
(marked by LEU2), whereas the large segregants were all
Leu2. Thus, SEC35 is not an essential gene although the
small colony size of the sec35D haploid indicates a severe
growth defect in the absence of SEC35.
In contrast, when dissected tetrads were incubated at
218C a 21:22 segregation for viability was observed (Fig. 2
b). All viable spores were Leu2 and thus SEC35 is an es-
sential gene at this temperature. Examination of the termi-
nal phenotype of the sec35D haploid segregants revealed
microcolonies of z25 cells and thus spores deleted for
SEC35 can germinate and undergo four or five cell divi-
sions before terminating vegetative growth. Transforma-
tion of the sec35D/SEC35 heterozygous diploid strain with
a plasmid encoding SEC35 before sporulation and dissec-
Figure 2. A haploid strain
containing a deletion of
SEC35 exhibits a severe
growth defect at 308C and is
inviable at 218C; the cold-
sensitive lethality can be res-
cued by the expression of
SEC35, low levels of SLY1-20,
or high levels of YPT1. The
sec35D/SEC35  heterozygous
deletion strain alone (a and
b), or transformed with
pSEC35  (CEN) ( c ), pYPT1
(2mm) ( d ), or pSLY1-20
(CEN)  (e) was sporulated and
dissected. The resulting tet-
rads were incubated at 308C
for 7 d (a) or at 218C for 5 d
(b and c) or 7 d (d and e) on
YPD plates. In c–e, only tet-
rads containing four viable
spores are shown; tetrads
with two or three viable spores
were assumed to result from
tetrads in which one or both
of the sec35D haploid spores
failed to receive the suppress-
ing plasmid.VanRheenen et al. Sec35p Is Required for Vesicle Docking 1113
tion complemented the cold-sensitive lethality of the
sec35D haploid, resulting in 41:02 segregation for viability
(Fig. 2 c). Of the tetrads with four viable spores, the dele-
tion (marked by LEU2) segregated 21:22, and the sec35D
haploid colonies were invariably Ura1 due to their reli-
ance on the plasmid for viability.
Multicopy Suppression Analysis
To gain insight into the function of Sec35p we undertook a
systematic analysis of its genetic interactions with other
genes involved in secretion. Since the sec35-1 mutant accu-
mulates vesicles and is likely to be involved in vesicular
docking or fusion, we first examined the interaction of
SEC35 with other genes known to be involved in this step.
To do this, we tested the ability of several known genes to act
as multicopy suppressors of the sec35-1 temperature-sensi-
tive growth defect. As shown in Fig. 3, the temperature
sensitivity of sec35-1 could be suppressed by overexpres-
sion of YPT1 from a 2-mm plasmid, or by low-copy expres-
sion of the dominant mutation of SLY1, termed SLY1-20
(Ossig et al., 1991). YPT1 expressed from a low-copy
(CEN) plasmid could also suppress the temperature-sensi-
tive growth defect, although to a slightly lower level than
the high-copy plasmid (data not shown). Thus, SEC35 dis-
plays a strong genetic interaction with two genes, YPT1
and SLY1, whose protein products are implicated in the
regulation of vesicle docking (Rexach and Schekman, 1991;
Segev, 1991; Lian et al., 1994; Søgaard et al., 1994; Lupashin
et al., 1996; Lupashin and Waters, 1997). In contrast, high-
copy expression of a third gene with a potential role in the
regulation of vesicle docking, USO1 (Sapperstein et al.,
1996), was incapable of suppressing sec35-1. Overexpres-
sion of the wild-type allele of SLY1 was also unable to sup-
press the growth defect of the sec35-1 strain, emphasizing
the unique function of the SLY1-20 allele. To determine
the specificity of the suppression of sec35-1 by YPT1, we
also tested SEC4, a yeast YPT1 homologue involved in the
docking stage of Golgi to plasma membrane transport
(Goud et al., 1988). SEC4, however, was unable to sup-
press the growth defect when expressed from a 2-mm plas-
mid (data not shown), indicating that the suppression of
sec35-1 by YPT1 is specific.
The sec35-1 strain could also be suppressed, although to
a much lesser extent, by overexpression of three v-SNAREs
involved in docking vesicles to the cis-Golgi, Sec22p,
Bet1p, and Ykt6p (Newman and Ferro-Novick, 1987; Os-
sig et al., 1991; Søgaard et al., 1994; McNew et al., 1997)
(Fig. 3). A fourth v-SNARE, Bos1p, (Shim et al., 1991;
Newman et al., 1992), however, was incapable of suppress-
ing the sec35-1 defect (data not shown). Interestingly,
when the genes encoding the two v-SNAREs required for
Golgi to plasma membrane transport, SNC1 and SNC2
(Gerst et al., 1992; Protopopov et al., 1993), were tested
for high-copy suppression of the sec35-1 temperature sen-
sitivity, SNC2 was found to suppress the defect as well as,
if not better than, each of the ER to Golgi v-SNAREs. In
contrast, SNC1 had no effect (data not shown).
A number of other genes were also tested for the ability
to suppress sec35-1 when expressed from 2-mm plasmids,
including those encoding the ER to Golgi t-SNARE SED5
(Hardwick and Pelham, 1992), the putative intra-Golgi
retrograde SNARE SFT1 (Banfield et al., 1995), the multi-
functional v-SNARE VTI1 (Fischer von Mollard et al.,
1997; Lupashin et al., 1997), a novel ER to Golgi transport
factor BET3 (Rossi et al., 1995), and the GDP dissociation
inhibitor  SEC19, also known as GDI1 (Garrett et al.,
1994). None of these genes improved the growth of sec35-1
at the restrictive temperature.
Because  SLY1-20 and high-copy YPT1 strongly sup-
pressed the temperature-sensitive allele of SEC35, we next
tested whether they were capable of suppressing the cold-
sensitive lethality of the genomic deletion. The heterozy-
gous deletion strain was transformed with plasmids encod-
ing either high levels of YPT1 or CEN levels of SLY1-20,
sporulated, and then subjected to tetrad analysis. After in-
cubation at room temperature for 7 d, the majority of the
tetrads contained three or four viable spores (Fig. 2, d and
e), rather than the 21:22 segregation evident without the
plasmid (Fig. 2 c). The sec35D haploid colonies (marked
by LEU2) were without exception Ura1, and thus were vi-
able by virtue of the suppressing plasmid. Suppression of
the deletion is not complete, however, as indicated by the
small size of the haploid colonies bearing the deletion
compared with the wild-type segregants in each tetrad.
The ability of SLY1-20 and high-copy YPT1 to suppress
the deletion of SEC35 implies that their protein products
function either downstream from, or in a parallel pathway
with, Sec35p.
If Sec35p and Ypt1p were functioning in parallel path-
ways, one might expect the genetic interactions to be re-
ciprocal in nature, and thus a temperature-sensitive allele
of YPT1 might be suppressed by high level expression of
SEC35. To test this hypothesis, the ypt1-3 strain was trans-
formed with a 2-mm plasmid encoding SEC35 and then
suppression was tested at the restrictive temperature. Al-
though the levels of Sec35p expressed from the plasmid
were z203 the genomic level (see Fig. 6), a high level of
Sec35p was incapable of compensating for the tempera-
ture sensitivity of ypt1-3 (data not shown). This result im-
Figure 3. Suppression of the temperature-sensitive growth phe-
notype of the sec35-1 strain. Wild-type and sec35-1 strains con-
taining the indicated plasmids were grown to stationary phase in
synthetic media and used for a series of 10-fold dilutions. The sta-
tionary phase culture and five serial dilutions of each strain were
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plies that Ypt1p may function downstream of Sec35p, but
the possibility of a parallel pathway cannot be completely
ruled out. The ability of 2-mm–expressed SEC35 to sup-
press temperature-sensitive mutations in many other genes
required for ER to Golgi transport was also tested. High
levels of Sec35p were expressed in each of the following
strains but were unable to suppress the growth defect at
the restrictive temperatures: sec22-3, bos1-1, bet1-1 (ER to
Golgi v-SNAREs), sec18-1 (yeast NSF), uso1-1 (ER to
Golgi docking factor), sly1ts (t-SNARE–associated pro-
tein),  bet3-1 (novel ER to Golgi factor), sft1-1 (putative ret-
rograde t-SNARE), sec19-1 (GDP-dissociation inhibitor),
sec4-8 (Golgi to plasma membrane rab-like GTPase),
sec21-1 (g-COP), sec27-1 (b9-COP), ret1-1 (a-COP), and
sec34-2 (novel ER to Golgi factor).
Suppression of the ER to Golgi Transport Block of the 
sec35-1 Strain by SLY1-20 and High-Copy YPT1
To confirm that the suppression of the temperature-sensi-
tive growth defect of the sec35-1 strain by SLY1-20 and
YPT1 was due to a direct effect on secretion, we tested
whether expression of either gene could suppress the ER
to Golgi transport defect. Thus, we examined the ability of
CPY to transit from the ER to the vacuole in the mutant
strain expressing low levels of SLY1-20 or high levels of
YPT1 (Fig. 4). In wild-type cells, CPY is translocated into
the ER where it is glycosylated, producing a 67-kD form
termed p1 (Stevens et al., 1982). The oligosaccharides are
extended in the Golgi generating the p2 form. Finally,
upon transport to the vacuole, CPY is proteolytically pro-
cessed to the 61-kD mature form. To examine progress of
CPY through the secretory pathway, we performed a
pulse-chase analysis of CPY maturation. Strains were
shifted to the restrictive temperature for 45 min, labeled
with Tran35S-label for 10 min, and then chased for 20 min
with an excess of unlabeled cysteine and methionine. CPY
was then immunoprecipitated, separated by SDS-PAGE,
and then visualized by autoradiography. Wild-type and
sec18-1 strains served as controls for the mature and p1
forms of CPY, respectively. Whereas the sec35-1 strain ac-
cumulated the p1 form of CPY, as shown previously
(Wuestehube et al., 1996), the expression of Sly1-20p or
Ypt1p was capable of suppressing the ER to Golgi defect
(Fig. 4), resulting in the procession of the majority of CPY
to its mature form. Nevertheless, since a significant
amount of the p1 form of CPY did accumulate, neither of
these proteins was capable of full suppression of the sec35-1
defect. A plasmid bearing the wild-type SEC35 gene, how-
ever, was capable of completely restoring the secretory
block and all CPY was found in the mature form.
sec35-1 Displays a Synthetic Interaction with ypt1-3 
and uso1-1
To further define the genetic interactions of SEC35 we
tested whether the sec35-1 strain displayed a synthetic le-
thal interaction with mutant alleles of other known genes
in the secretory pathway. Thus, the sec35-1 strain was
mated individually to several strains each containing a
temperature-sensitive mutation in one of the known secre-
tory genes and the resulting diploids were sporulated and
dissected. Due to the suppression of sec35-1 by YPT1, we
first tested whether the mutant alleles of the two genes
would display a synthetic interaction. Incubation of dis-
sected tetrads from the diploid strain heterozygous for
both  sec35-1 and ypt1-3 at 308C, a temperature permissive
for both mutations, resulted in a pattern of viable spores
consistent with a synthetic lethal interaction between the
two alleles (Fig. 5 a): tetrads consisting of four viable
spores segregated 01:42 for temperature sensitivity (pa-
rental ditypes), tetrads consisting of two viable spores seg-
regated 21:02 for temperature sensitivity (nonparental
ditypes), and tetrads consisting of three viable spores seg-
regated 11:22 for temperature-sensitivity (tetratypes). In
all cases the inviable progeny must be the haploid seg-
regant bearing both the sec35-1 and the ypt1-3 mutation.
Although we failed to see a genetic interaction between
SEC35 and USO1 through multicopy suppression analysis,
Figure 4. Suppression of the ER to Golgi transport defect of
sec35-1 by expression of SLY1-20 or high levels of YPT1. Wild-
type and sec18-1 strains, as well as the sec35-1 strain with and
without the indicated plasmids, were grown at 218C to mid-loga-
rithmic phase and then shifted to 398C for 45 min. Cells were la-
beled at 398C for 10 min with Tran35S-label and then chased for
20 min at the same temperature. CPY was immunoprecipitated
from each strain, resolved by SDS-7%PAGE, and then visualized
by autoradiography. The migration of the ER precursor (p1) and
mature (m) forms of CPY are indicated on the left.
Figure 5. The sec35-1 allele exhibits a synthetic interaction with
ypt1-3 and uso1-1. The sec35-1 strain was mated to a strain bear-
ing the ypt1-3 allele (a) or the uso1-1 allele (b), and the resulting
diploid strains were sporulated, dissected on YPD plates, and
then incubated at 308C for 3 d. Six representative tetrads of each
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we tested whether mutations in the two genes displayed a
synthetic interaction. Analysis of tetrads from a diploid
strain heterozygous for both sec35-1 and uso1-1 revealed a
pattern of viability identical to that seen with the seg-
regants from the diploid heterozygous for both sec35-1
and  ypt1-3 (Fig. 5 b). This synthetic lethal interaction is the
first genetic interaction that has been observed between
SEC35 and USO1. Interestingly, when tetrads dissected
from diploid strains heterozygous for both sec35-1 and
ypt1-3 or sec35-1 and uso1-1 were incubated at 218C, all
spores were viable (data not shown). The interaction be-
tween sec35-1 and both ypt1-3 and uso1-1 is best described
as a conditional synthetic lethality.
Localization of Sec35p
To initiate a biochemical analysis of Sec35p, recombinant
Sec35p was used to generate anti-Sec35p antibodies in
rabbits. The polyclonal serum was affinity purified on bac-
terially expressed His6-Sec35p and used to probe total
yeast protein extracts. As shown in Fig. 6, the affinity-puri-
fied anti-Sec35p antibody specifically recognizes a protein
of z35 kD, close to the predicted mol wt of 31.8 kD. This
band was absent in a strain deleted for SEC35 (expressing
SLY1-20 from a CEN plasmid to suppress the sec35D
growth defect), and is thus specific for Sec35p. As ex-
pected, Sec35p is highly overexpressed in a strain bearing
a 2-mm SEC35 plasmid. In the temperature-sensitive
sec35-1 strain incubated at either the permissive or the re-
strictive temperatures, the truncated 24-kD protein pre-
dicted from the sequence of the sec35-1 allele is not de-
tected, indicating that the mutation greatly decreases the
stability of the protein. However, upon longer exposure of
the immunoblot the fragment of Sec35p was visible, mi-
grating with an apparent mol wt of 27 kD. This truncated
Sec35p is more abundant at the permissive temperature
than at the restrictive temperature (data not shown).
We next tested whether there existed a membrane-asso-
ciated pool of Sec35p, as might be predicted for a protein
required for membrane traffic. Wild-type yeast were lysed
with glass beads and centrifuged at 1,000 g for 3 min to re-
move unbroken cells, yielding the low-speed supernatant
S1. The S1 supernatant was then centrifuged at 175,000 g
for 60 min and separated into pellet (P175) and superna-
tant (S175) fractions that should contain the membrane-
bound and soluble proteins, respectively. The P175 and
S175 fractions were resolved by SDS-PAGE and immuno-
blotted with affinity-purified antibodies against Sec35p,
the cis-Golgi protein Sed5p, and the cytosolic protein
PGK. As shown in Fig. 7 a, approximately two-thirds of
Sec35p is found in the P175 fraction, and thus a significant
proportion of the protein may be membrane-associated.
As expected of an integral membrane protein, Sed5p lo-
calizes to the P175 fraction, whereas the cytosolic protein
PGK remains in the supernatant fraction. Although we
consistently observe a fraction of Sec35p in the P175 pel-
let, the proportion of pelletable protein is variable, rang-
ing from about one-third to two-thirds of the total Sec35p
(data not shown).
The localization of Sec35p was then examined through
subcellular fractionation. The S1 fraction described above
was centrifuged at 10,000 g for 15 min, yielding the P10
Figure 6. Characterization of
the affinity-purified anti-
Sec35p antibody. Extracts
were made by glass bead lysis
from logarithmically grow-
ing strains: wild-type, sec35D
transformed with pSLY1-20
(CEN), wild-type trans-
formed with pSEC35 ( 2 m m ),
and sec35-1. All strains were
incubated at 218C before ly-
sis except for the sec35-1
strain, which was maintained
at 218C or shifted to 388C for
1 h before lysis. Extracts (0.2
OD595 per lane) were sepa-
rated by SDS-12%PAGE
and immunoblotted with affinity-purified anti-Sec35p antibodies.
The migration of mol wt markers is shown on the right.
Figure 7. Sec35p is a peripheral membrane protein. (a) Sec35p
partitions into soluble and membrane-associated pools. A wild-
type strain was grown to logarithmic phase, lysed with glass
beads, and then centrifuged at 1,000 g for 3 min to generate the
S1 supernatant fraction. The S1 supernatant was centrifuged at
175,000 g to obtain the S175 supernatant and P175 pellet frac-
tions. (b) The membrane-associated portion of Sec35p fraction-
ates similarly to the Golgi protein, Sed5p. The S1 supernatant
was centrifuged at 10,000 g to generate the S10 supernatant and
P10 pellet fractions, and the S10 was subsequently centrifuged at
175,000 g to obtain the S175 supernatant and P175 pellet frac-
tions. (c) Sec35p behaves as a peripheral membrane protein. The
S1 supernatant was incubated with buffer 88, 1% Triton X-100,
1 M NaCl, or 100 mM Na2CO3, pH 11, centrifuged at 175,000 g,
and separated into supernatant and pellet fractions. (a–c) Ali-
quots of each fraction were separated by SDS-12%PAGE and
immunoblotted with affinity-purified anti-Sec35p (top panel),
anti-Sed5p (center panel), or anti-PGK (bottom panel) antibodies.
The samples loaded in each lane were derived from equivalent
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pellet and S10 supernatant fractions, and the S10 was fur-
ther centrifuged at 175,000 g for 60 min to generate the
P175 pellet and S175 supernatant fractions. With this se-
ries of differential centrifugation steps, all organelles of
the secretory pathway should be contained in one or more
of the pellet fractions: the ER and vacuole are located pri-
marily in the P10 fraction, whereas the Golgi partitions be-
tween the P10 and P175 fractions (Walworth et al., 1989;
Nakayama et al., 1992). To determine the localization of
Sec35p, the supernatant and pellet fractions were resolved
by SDS-PAGE and immunoblotted with affinity-purified
antibodies. As shown in Fig. 7 b, although a portion of
Sec35p once again remains in the S175, the membrane-
associated pool of Sec35p partitions between the P10 and
P175 fractions. The fractionation pattern of the mem-
brane-associated Sec35p is similar to that of the cis-Golgi
marker Sed5p, which also localizes to the P10 and P175
fractions. Nonetheless, because of the large pool of soluble
Sec35p and the labile nature of its membrane association
in vitro (data not shown), we have been unable to un-
equivocally determine its precise subcellular localization.
Finally, to determine whether the membrane association
of Sec35p is as an integral or peripheral membrane pro-
tein, we attempted to extract the protein from the mem-
brane using detergent, high salt, or high pH. Although
both integral and peripheral membrane proteins should be
extracted by detergent that solubilizes the membranes, the
hallmark of a peripheral membrane protein is the ability
to be extracted by salt or high pH, conditions which often
disrupt protein–protein interactions. The S1 supernatant
was thus incubated for 30 min on ice in either buffer, 1%
Triton X-100, 1 M sodium chloride, or 100 mM sodium
carbonate, pH 11, centrifuged at 175,000 g for 60 min, and
then separated into pellet and supernatant fractions. The
fractions were then resolved by SDS-PAGE and immuno-
blotted with antibodies against Sec35p, Sed5p, and PGK.
Whereas Sed5p and PGK behaved as expected for an inte-
gral membrane protein or a cytosolic protein, respectively
(Fig. 7 c), Sec35p was extractable by Triton X-100, NaCl,
and Na2CO3 and thus behaves as a peripheral membrane
protein.
Sec35p Is Required for ER to Golgi Vesicle Docking
Our genetic and biochemical experiments suggest that
Sec35p functions during the docking stage of ER to Golgi
transport perhaps through peripheral association with
membranes. To directly test this idea, we used a cell-free
assay that measures distinct stages of ER to Golgi trans-
port by following the radioactively labeled precursor of
the secretory protein a-factor, glycosylated pro-a-factor
([35S]gp-a-factor). Transport in semi-intact yeast cells may
be reproduced in vitro with washed membranes, purified
COPII proteins, Uso1p, a protein complex called LMA1
(Xu et al., 1997), and ATP (Barlowe, 1997). COPII-coated
vesicles that have budded from the ER are freely diffus-
ible and then dock to Golgi membranes upon addition of
Uso1p. Sec18p and LMA1 are not required for the dock-
ing phase, but are required for efficient fusion of vesicles
(Barlowe, 1997). These soluble proteins represent some,
but not all, of the genetically defined components for fu-
sion of ER-derived vesicles. Other proteins that are pe-
ripherally bound to membranes (such as Sly1p and Ypt1p)
or are integral membrane proteins (such as Sed5p, Bet1p
and Bos1p) have required schemes designed to selectively
inactivate their function in vitro such that reconstitution
experiments can be performed (Cao et al., 1998). To inac-
tivate Sec35p in vitro, we prepared membranes from the
temperature-sensitive sec35-1 strain and measured recon-
stituted ER to Golgi transport at restrictive temperatures.
In Fig. 8, semi-intact yeast cell membranes prepared
from a wild-type strain and the sec35-1 strain were incu-
bated with purified transport factors at 238 or 298C. Wild-
type membranes show a modest decrease in transport at
298C, whereas transport in the sec35-1 semi-intact mem-
branes is reduced to near background levels (Fig. 8, A and
B, compare open bars). This inhibition is specific for
Sec35p function because the addition of purified His6-
Sec35p (1.2 mg) restored transport in mutant membranes
to near wild-type levels at 298C (Fig. 8, A and B, compare
hatched bars). The restoration of transport was maximal
with 1.2 mg of His6-Sec35p, although stimulation could be
observed with as little as 0.24 mg (data not shown). Be-
cause no stimulation of transport was observed when His6-
Sec35p was added to wild-type reactions, it is likely that
ample levels of Sec35p are present on washed membranes.
However, we have established a specific requirement for
Sec35p in cell-free transport of [35S]gp-a-factor from the
ER to the Golgi when membranes are prepared from the
sec35-1 strain and reactions performed at 298C.
To further characterize Sec35p function in distinct trans-
port stages, we assayed vesicle docking in mutant sec35-1
semi-intact cells. For this assay, docking is measured as the
amount of COPII-generated vesicles that attach to Golgi
membranes in the presence of Uso1p. The docked vesicles
Figure 8. Sec35p is required for ER to Golgi transport in vitro.
Semi-intact yeast cell membranes prepared from wild-type (A) or
sec35-1 (B) strains were incubated at 238 or 298C for 60 min. Re-
actions contained an ATP regeneration system alone (No addi-
tion, solid bars), COPII, Uso1p, and LMA1 (Reconstituted, open
bars), or COPII, Uso1p, LMA1 and His6-Sec35p (Reconstituted
1 Sec35p, hatched bars). Outer-chain modified forms of [35S]gp-
a-factor were immunoprecipitated with anti–a1,6-mannose–spe-
cific antibodies and the percent transport reflects the amount of
total [35S]gp-a-factor that has acquired Golgi-specific outer-chain
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sediment with semi-intact cells after a brief centrifugation
step (Barlowe, 1997). As seen in Fig. 9, wild-type and
sec35-1 semi-intact membranes bud nearly equivalent
amounts of ER-derived vesicles when purified COPII pro-
teins are added at 238and 298C (Fig. 9, A and B, wide
hatched bars). Uso1p addition docked this intermediate
and reduced the level of freely diffusible vesicles in wild-
type reactions but docking was not efficient in reactions
containing sec35-1 membranes at the restrictive tempera-
ture (Fig. 9, A and B, compare open bars). Finally, the ad-
dition of purified His6-Sec35p restored docking efficiency
in sec35-1 membranes at 298C and did not alter the level of
docking in wild-type reactions (Fig. 9, A and B, narrow
hatched bars). In summary, ER to Golgi transport in
sec35-1 membranes is prevented because vesicles fail to
dock.
Discussion
sec35-1 is a novel secretory mutant identified in a genetic
screen for temperature-sensitive mutants that accumulate
unprocessed a-factor internally (Wuestehube et al., 1996).
The sec35-1 strain is defective in the transport of both sol-
uble and membrane proteins from the ER to the Golgi ap-
paratus. In addition, numerous vesicles accumulate at the
restrictive temperature, suggesting that there is a defect in
vesicle docking or fusion (Wuestehube et al., 1996). We
have cloned SEC35 and demonstrated that it encodes a
novel cytosolic protein of 32 kD. The cloned gene can sup-
press the temperature-sensitive growth defect, as well as
the ER to Golgi secretory defect, of the sec35-1 strain; it is
authentic SEC35 as shown by integrative mapping.
SEC35 displays a strong genetic interaction with two
genes whose protein products are involved in the regula-
tion of vesicle docking: the small GTP-binding protein
YPT1 and the t-SNARE–associated protein SLY1. The
temperature-sensitive growth defect of the sec35-1 strain is
suppressed by either high levels of YPT1 or low levels of a
dominant allele of SLY1, termed SLY1-20. Suppression of
the growth defect is due to a restoration of secretory path-
way function, since a vacuolar protein, CPY, which accu-
mulates in its ER-modified form in the sec35-1 strain, is
transported to the vacuole in the presence of SLY1-20 or
high-copy YPT1. Neither gene can completely replace the
function of SEC35, however, since only partial restoration
is obtained.
High levels of YPT1 or low levels of SLY1-20 can also
rescue the cold-sensitive lethality of the SEC35 deletion
strain. This suppression of the sec35D strain indicates that
both Ypt1p and Sly1p function downstream of, or in a par-
allel pathway with, Sec35p. However, overexpression of
SEC35 fails to suppress the temperature-sensitive growth
defect of either the ypt1-3 or the sly1ts strains, contrary to
what might be expected if Sec35p operates in a parallel
pathway. Thus, it seems more likely that Ypt1p and Sly1p
function downstream of Sec35p. Furthermore, since Ypt1p
acts upstream of the SNAREs and Sly1p to regulate
SNARE complex assembly (Søgaard et al., 1994; Lupashin
and Waters, 1997), Sec35p is likely to impinge on this pro-
cess as well.
The interpretation that Sec35p is involved in regulating
SNARE complex assembly is supported by the result that
overexpression of a number of v-SNAREs involved in
docking vesicles to the cis-Golgi (Sec22p, Bet1p, and
Ykt6p) are capable of suppressing the temperature-sensi-
tive growth defect of the sec35-1 strain, albeit to a lesser
extent than YPT1 or SLY1-20. This suppression may be
due to a mass action effect, in which increasing the amount
of one v-SNARE can drive v/t-SNARE complex forma-
tion to an extent sufficient to allow a low level of growth.
Intriguingly, the sec35-1 strain can also be suppressed by
overexpression of one of the Golgi to plasma membrane
v-SNAREs, SNC2. This suppression pattern suggests that
Sec35p may function at more than one step in the secre-
tory pathway. However, overexpression of the Golgi to
plasma membrane Ypt1p-like GTPase, SEC4, is unable to
suppress sec35-1. Attempts to address the effect of Sec35p
at multiple stages by preloading the secretory pathway of
the sec35-1 strain with labeled CPY and shifting to the
nonpermissive temperature were inconclusive, since the
temperature-sensitive defect of the sec35-1 strain is slow
relative to the rate of secretion (data not shown).
Multicopy suppression analysis failed to identify a ge-
netic interaction between SEC35 and the third gene whose
protein product has a role in the regulation of SNARE
complex assembly, USO1. However, mutations in SEC35,
USO1, and YPT1 exhibit a very similar pattern of suppres-
sion since each is suppressed by both SLY1-20 and ER to
Golgi v-SNAREs (Sapperstein et al., 1996). In addition,
the three genes are related through synthetic lethal inter-
actions: the sec35-1 allele is conditionally lethal in combi-
nation with either uso1-1 or ypt1-3, and uso1-1 displays a
synthetic lethal interaction with ypt1-3 (Sapperstein et al.,
1996). These data suggest that the functions of Sec35p,
Uso1p, and Ypt1p in ER to Golgi transport are intimately
associated.
At the ER to Golgi step of the secretory pathway it is
likely that v/t-SNARE complex formation occurs during
the docking phase of the reaction, before membrane fu-
Figure 9. Sec35p is required for vesicle docking. Semi-intact
yeast cell membranes prepared from wild-type or sec35-1 strains
were incubated at 238 or 298C for 30 min. Reactions contained an
ATP regeneration system alone (No addition, solid bars), COPII
(COPII, wide hatched bars), COPII and Uso1p (COPII 1 Uso1p,
open bars), or COPII, Uso1p, and His6-Sec35p (COPII, Uso1p 1
Sec35p, narrow hatched bars). Freely diffusible vesicles contain-
ing [35S]gp-a-factor were separated from semi-intact membranes
by centrifugation at 18,000 g for 3 min. The percent diffusible ves-
icles reflects the amount of total concanavalin A precipitable
[35S]gp-a-factor contained in the 18,000 g supernatant fluid.The Journal of Cell Biology, Volume 141, 1998 1118
sion. This interpretation is based on the observation that
Sec18p (NSF), which is required to disassemble v/t-
SNARE complexes (Söllner et al., 1993a,b) allows docked
vesicles to fuse in vitro (Barlowe, 1997). Because our ge-
netic analysis indicates that Sec35p functions the docking
step, we tested this hypothesis directly using an in vitro as-
say that monitors individual stages of ER to Golgi trans-
port. In this cell-free assay, vesicle budding from washed
semi-intact cells requires the addition of COPII compo-
nents, whereas docking is dependent upon both COPII
proteins and Uso1p. Membranes isolated from the sec35-1
strain and incubated at the restrictive temperature were
found to be competent for vesicle formation but defective
in Uso1p-dependent vesicle docking. Thus, Sec35p ap-
pears to be required for the docking of ER-derived vesicles.
Sec35p was not identified as one of the cytosolic compo-
nents required for vesicle docking in wild-type semi-intact
cells (Barlowe, 1997). In addition, purified Sec35p does
not stimulate docking in wild-type cells and thus sufficient
Sec35p is present in the cytosol-free membranes to pro-
vide its essential function. These results indicate that
Sec35p is associated with membranes. Indeed, we find that
a significant portion of Sec35p behaves as a peripheral
membrane protein, potentially associating with the Golgi.
The above in vitro data from wild-type cells implies that
the membrane-associated pool of Sec35p may be the func-
tional form of this protein since neither the removal of sol-
uble Sec35p nor the addition of recombinant Sec35p af-
fects docking. It is possible, however, that either the
soluble fraction of Sec35p is not removed with the washes
or that very little Sec35p, soluble or membrane-associated,
is required for function.
Recent results from a number of laboratories suggest
the following outline for ER to Golgi transport. First, vesi-
cle budding occurs under the direction of COPII proteins
resulting in a freely diffusible vesicle (Barlowe et al., 1994).
Docking then occurs in two stages: in the first stage, the
vesicle is “tethered” to the Golgi in a reaction that requires
Uso1p and Ypt1p (Cao et al., 1998) while the second stage
may be a SNARE-dependent event characterized by an as-
sembled v/t-SNARE complex spanning the vesicle and target
membrane, as proposed in the original SNARE hypothesis
(Söllner et al., 1993b). In this case, the role of Uso1p and
Ypt1p in the regulation of SNARE-complex assembly
(Sapperstein et al., 1996; Lupashin and Waters, 1997) may
equate to a dependence on the tethered state for SNARE-
dependent docking. After docking, Sec18p would act to
disassemble the v/t-SNARE complex and allow the reac-
tion to proceed towards fusion. What is perhaps least clear
in this scenario for ER to Golgi transport is the exact role
of Sec18p in facilitating progression towards fusion. For ex-
ample, it is possible that Sec18p acts to disassemble v/t-
SNARE complexes within (not across) the vesicle and/or
target membranes of the tethered intermediate. This disas-
sembly would allow the freed v- and t-SNAREs to enter
into new v/t-SNARE complexes that span the vesicle and
target membranes. Fusion could then ensue without a fur-
ther requirement for Sec18p, as suggested by the recent
work on vacuole fusion in yeast (Mayer et al., 1996; Mayer
and Wickner, 1997) and the reconstitution of membrane
fusion with SNAREs alone (Weber et al., 1998). The essen-
tial difference in the models is that the first (tethering ®
SNARE-dependent docking ® Sec18p function ® fusion)
a vesicle-target membrane-spanning v/t-SNARE complex
is disassembled by Sec18p, allowing fusion, whereas in the
second model (tethering ® Sec18p function ® SNARE-
dependent docking ® fusion) the vesicle-target mem-
brane-spanning v/t-SNARE complex is, in effect, generated
by Sec18p and proceeds spontaneously to fusion. Regard-
less of the precise role of Sec18p in generating or consum-
ing a SNARE-docked state, our genetic and biochemical
results clearly place Sec35p as acting in the Uso1p-depen-
dent docking phase of ER to Golgi vesicle docking.
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